University of Groningenfounded in 1614  -  top 100 university
Close
How to find us prof. dr. T.L. (Talitha) Feenstra

prof. dr. T.L. (Talitha) Feenstra

Associate professor, economic evaluation of precision medicine

prof. dr. T.L. (Talitha) Feenstra
Telephone:
+31 50 36 32607 (office)
extra phone:
+31 30 274 4387 (RIVM (Monday))
E-mail:
t.l.feenstra rug.nl

Research

Research units:

Postal address:
A Deusinglaan1
9713 AV
Groningen
Netherlands
Advanced
Advanced

Reset

to
1 - 50 out of 188Page size: 50
  1. 2020
  2. Pagano, E., Konings, S. R., Di Cuonzo, D., Rosato, R., Bruno, G., van der Heijden, A. A., Beulens, J., Slieker, R., Leal, J., & Feenstra, T. L. (2020). Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UKPDS outcomes model version 2 in two European observational cohorts. Diabetes obesity & metabolism. https://doi.org/10.1111/dom.14311
  3. Tuvdendorj, A., Du, Y., Sidorenkov, G., Buskens, E., de Bock, G. H., & Feenstra, T. (2020). Informing policy makers on the efficiency of population level tobacco control interventions in Asia: A systematic review of model-based economic evaluations. Journal of global health, 10(2), 020437. https://doi.org/10.7189/jogh.10.020437
  4. Ramaekers, B. L. T., Wijnen, B., Armstrong, N., Petersohn, S., Feenstra, T., Wang, J., & Joore, M. A. (2020). Comment on "External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions". Pharmacoeconomics, (1), 133-135. https://doi.org/10.1007/s40273-020-00985-5
  5. Konings, S. R. A., Bruggeman, R., Visser, E., Schoevers, R. A., Mierau, J. O., & Feenstra, T. L. (2021). Episode detection based on personalized intensity of care thresholds: a schizophrenia case study. Social Science & Medicine, 270, [113507]. https://doi.org/10.1016/j.socscimed.2020.113507
  6. Emamipour, S., van der Heijden, A. A. W. A., Nijpels, G., Elders, P. J. M., Beulens, J. W. J., Postma, M., Boven, van, J., & Feenstra, T. L. (2020). A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspective. Diabetologia, 63(11), 2452-2461. https://doi.org/10.1007/s00125-020-05239-9
  7. Kan, K., Feenstra, T. L., de Vries, S. O., Visser, E., Schoevers, R. A., & Jorg, F. (2020). The clinical effectiveness of an algorithm-guided treatment program for depression in specialized mental healthcare: A comparison with efficacy trials. Journal of Affective Disorders, 275, 216-223. https://doi.org/10.1016/j.jad.2020.07.010
  8. Sanches, S. A., Swildens, W. E., Schaefer, B., Moerbeek, M., Feenstra, T. L., van Asselt, A. D. I., Danner, U. N., van Weeghel, J., & van Busschbach, J. T. (2020). Effectiveness of the Boston University Approach to Psychiatric Rehabilitation in Improving Social Participation in People With Severe Mental Illnesses: A Randomized Controlled Trial. Frontiers in Psychiatry, 11, [571640]. https://doi.org/10.3389/fpsyt.2020.571640
  9. Si, L., Willis, M. S., Asseburg, C., Nilsson, A., Tew, M., Clarke, P. M., Lamotte, M., Ramos, M., Shao, H., Shi, L., Zhang, P., McEwan, P., Ye, W., Herman, W. H., Kuo, S., Isaman, D. J., Schramm, W., Sailer, F., Brennan, A., ... Palmer, A. J. (2020). Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge. Value in Health, 23(9), 1163-1170. https://doi.org/10.1016/j.jval.2020.04.1832
  10. Mohnen, S. M., Feenstra, T. L., Wendel-Vos, W., & de Wit, A. (2020, Jun). Gecombineerde leefstijlinterventie 2020: ontwikkeling in volle gang. Rijksinstituut voor Volksgezondheid en Milieu RIVM. https://www.rivm.nl/documenten/factsheet-tweede-monitor-gecombineerde-leefstijlinterventie-1
  11. Wang, J., Phi, X-A., Greuter, M. J. W., Daszczuk, A. M., Feenstra, T. L., Pijnappel, R. M., Vermeulen, K. M., Buls, N., Houssami, N., Lu, W., & de Bock, G. H. (2020). The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program. European Radiology, 30(10), 5437-5445. https://doi.org/10.1007/s00330-020-06812-x
  12. van der Heijden, A. A., Nijpels, G., Badloe, F., Lovejoy, H. L., Peelen, L. M., Feenstra, T. L., Moons, K. G. M., Slieker, R. C., Herings, R. M. C., Elders, P. J. M., & Beulens, J. W. (2020). Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting. Diabetologia, 63(6), 1110-1119. https://doi.org/10.1007/s00125-020-05134-3
  13. Tuvdendorj, A., Feenstra, T., Tseveen, B., & Buskens, E. (2020). Smoking-attributable burden of lung cancer in Mongolia a data synthesis study on differences between men and women. PLoS ONE, 15(2), [e0229090]. https://doi.org/10.1371/journal.pone.0229090
  14. Looijmans, A., Jorg, F., Bruggeman, R., Schoevers, R. A., Corpeleijn, E., Feenstra, T. L., & van Asselt, A. D. I. (2020). Cost-effectiveness and budget impact of a lifestyle intervention to improve cardiometabolic health in patients with severe mental illness. Global & regional health technology assessment, 7(1), 131-138. https://doi.org/10.33393/grhta.2020.2027
  15. Feenstra, T. L., Knies, S., Ramaekers, B. L. T., & Koffijberg, E. (2020). Gezondheids-economische beslismodellen: de stand van zaken en de toekomst. VGE Informatie Bulletin, 24-27. [maart 2020].
  16. 2019
  17. Mohnen, S. M. (Author), Feenstra, T. L. (Author), Wendel-Vos, G. C. (Author), & de Wit, G. A. (Author). (2019). Monitor: Gecombineerde Leefstijlinterventie (GLI-Monitor). Web publication/site, RIVM. https://www.rijksoverheid.nl/binaries/rijksoverheid/documenten/brochures/2019/12/09/monitor-gecombineerde-leefstijlinterventie-gli-monitor/monitor-gecombineerde-leefstijlinterventie-gli-monitor.pdf
  18. Wasir, R., Irawati, S., Makady, A., Postma, M., Goettsch, W., Feenstra, T., & Buskens, E. (2019). The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders. PLoS ONE, 14(11), [e0225626]. https://doi.org/10.1371/journal.pone.0225626
  19. Kan, K., Jörg, F., Wardenaar, K. J., Blaauw, F. J., Visser, E., Buskens, E., Mulder, H., Cath, D., Doornbos, B., Schoevers, R. A., & Feenstra, T. (2019). Ai3 development of a decision-aid for patients with depression considering treatment options: Prediction of treatment response using a data-driven approach. Value in Health, 22, S404. https://doi.org/10.1016/j.jval.2019.09.043
  20. Emamipour, S., van der Heijden, A. A. W. A., Postma, M., van Boven, J. F. M., & Feenstra, T. (2019). PDB34 A PERSONALIZED SCREENING STRATEGY FOR DIABETIC RETINOPATHY: A COST-EFFECTIVENESS PERSPECTIVE. Value in Health, 22, 578. https://doi.org/10.1016/j.jval.2019.09.916
  21. Konings, S., Bruggeman, R., Mierau, J. O., Feenstra, T., Visser, E., & Schoevers, R. A. (2019). PERSONALIZED HEALTHCARE EPISODE IDENTIFICATION IN SCHIZOPHRENIA SPECTRUM DISORDER USING HEALTHCARE CONSUMPTION TRAJECTORIES. Value in Health, 22, 689. [PMH49]. https://doi.org/10.1016/j.jval.2019.09.1523
  22. Kent, S., Becker, F., Feenstra, T., Tran-Duy, A., Schlackow, I., Tew, M., Zhang, P., Ye, W., Lizheng, S., Herman, W., McEwan, P., Schramm, W., Gray, A., Leal, J., Lamotte, M., Willis, M., Palmer, A. J., & Clarke, P. (2019). The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood. Pharmacoeconomics, 37(11), 1305-1312. https://doi.org/10.1007/s40273-019-00825-1
  23. Rodriguez-Sanchez, B., Feenstra, T. L., Bilo, H. J. G., & Alessie, R. J. M. (2019). Costs of people with diabetes in relation to average glucose control: an empirical approach controlling for year of onset cohorts. European Journal of Health Economics, 20(7), 989-1000. https://doi.org/10.1007/s10198-019-01072-z
  24. Beulens, J. W., Yauw, J. S., Peelen, L. M., Feenstra, T. L., Moons, K. G., Slieker, R. C., Herings, R. M., Elders, P. J., Nijpels, G., & van der Heijden, A. A. (2019). Prediction models for the risk of diabetic foot in people with type 2 diabetes: a systematic review and external validation study. Diabetologia, 62, S459-S460.
  25. Nijpels, G., Yauw, J., Feenstra, T., Baan, C., Beulens, J., Elders, P., Herings, R., Moons, K., Slieker, R., Peelen, L., & van der Heijden, A. (2019). Prediction of macrovascular events and mortality in people with type 2 diabetes using dynamic modelling of systolic blood pressure: the Hoorn Diabetes Care System cohort. Diabetologia, 62, S573-S573.
  26. Slobbe, L. C. J., Füssenich, K., Wong, A., Boshuizen, H. C., Nielen, M. M. J., Polder, J. J., Feenstra, T. L., & van Oers, H. A. M. (2019). Estimating disease prevalence from drug utilization data using the Random Forest algorithm. European Journal of Public Health, 29(4), 615-621. https://doi.org/10.1093/eurpub/cky270
  27. Leal, J., Morrow, L. M., Khurshid, W., Pagano, E., & Feenstra, T. (2019). Decision models of prediabetes populations: A systematic review. Diabetes obesity & metabolism, 21(7), 1558-1569. https://doi.org/10.1111/dom.13684
  28. Feenstra, T. L., & Buskens, E. (2019). Organized Session: Sin Taxes, Their Health and Fiscal Consequences. Applications in OECD and Asian Countries.. Abstract from 13th International Health Economics Association (IHEA) World Congress 2019, Basel, Switzerland.
  29. Wijnen, B. F. M., Thielen, F. W., Konings, S., Feenstra, T., Van der Gaag, M., Veling, W., De Haan, L., Ising, H., Hiligsmann, M., Evers, S. M. A. A., Smit, F., & Lokkerbol, J. (2019). Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis. Expert review of pharmacoeconomics & outcomes research. https://doi.org/10.1080/14737167.2019.1632194
  30. Phi, X-A., Greuter, M. J. W., Obdeijn, I-M., Oosterwijk, J. C., Feenstra, T. L., Houssami, N., & de Bock, G. H. (2019). Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis. The Breast, 45, 82-88. https://doi.org/10.1016/j.breast.2019.03.004
  31. Suijkerbuijk, A. W. M., Over, E. A. B., Opsteegh, M., Deng, H., van Gils, P. F., Marinovic, A. A. B., Lambooij, M., Polder, J. J., Feenstra, T. L., van der Giessen, J. W. B., de Wit, G. A., & Mangen, M-J. J. (2019). A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis. PLoS ONE, 14(5), [0216615]. https://doi.org/10.1371/journal.pone.0216615
  32. Wasir, R., Irawati, S., Makady, A., Postma, M., Goettsch, W., Buskens, E., & Feenstra, T. (2019). Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia. PLoS ONE, 14(2), [e0212328]. https://doi.org/10.1371/journal.pone.0212328
  33. Irawati, S., Wasir, R., Floriaan Schmidt, A., Islam, A., Feenstra, T., Buskens, E., Wilffert, B., & Hak, E. (2019). Long-term incidence and risk factors of cardiovascular events in Asian populations: systematic review and meta-analysis of population-based cohort studies. Current Medical Research and Opinion, 35(2), 291-299. https://doi.org/10.1080/03007995.2018.1491149
  34. Füssenich, K., Nusselder, W. J., Lhachimi, S. K., Boshuizen, H. C., & Feenstra, T. F. (2019). Potential gains in health expectancy by improving lifestyle: an application for European regions. Population health metrics, 17(1). https://doi.org/10.1186/s12963-018-0181-5
  35. Meeuwissen, J. A. C., Feenstra, T. L., Smit, F., Blankers, M., Spijker, J., Bockting, C. L. H., van Balkom, A. J. L. M., & Buskens, E. (2019). The cost-utility of stepped-care algorithms according to depression guideline recommendations - Results of a state-transition model analysis. Journal of Affective Disorders, 242, 244-254. https://doi.org/10.1016/j.jad.2018.08.024
  36. Eggleston, K., Chen, B. K., Chen, C-H., Chen, Y. I., Feenstra, T., Iizuka, T., Lam, J. T., Leung, G. M., Lu, J. R., Rodriguez-Sanchez, B., Struijs, J. N., Quan, J., & Newhouse, J. P. (2019). Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems. National Bureau of Economic Research, Inc, NBER Working Papers: 25971. https://doi.org/10.3386/w25971
  37. Becker, F., Feenstra, T., Pagano, E., & Leal, J. (2019). Choice of Statistical Model for Estimating Health State Utility for Economic Models: A Case Study Using Quality of Life Data from Individuals at High Risk for Diabetes. Abstract from 13th International Health Economics Association (IHEA) World Congress 2019, Basel, Switzerland.
  38. Feenstra, T. (2019). Trends in Health Economic Modeling and Implications for Validation..
  39. 2018
  40. Wasir, R., Irawati, S., Makady, A., Postma, M. J., Goettsch, W., Feenstra, T. L., & Buskens, E. (2018). Barriers to and facilitators of the application of health technology assessment in medicine pricing and reimbursement policies in indonesia. Value in Health, 21, S184. https://doi.org/10.1016/j.jval.2018.09.1099
  41. Wasir, R., Irawati, S., Makady, A., Postma, M. J., Goettsch, W., Feenstra, T., & Buskens, E. (2018). USE OF MEDICINE PRICING AND REIMBURSEMENT POLICIES FOR UNIVERSAL HEALTH COVERAGE IN INDONESIA. 1. https://doi.org/10.1016/j.jval.2018.09.004
  42. Wasir, R., Irawati, S., Makady, A., Postma, M. J., Goettsch, W., Feenstra, T., & Buskens, E. (2018). USE OF MEDICINE PRICING AND REIMBURSEMENT POLICIES FOR UNIVERSAL HEALTH COVERAGE IN INDONESIA. Value in Health, 21(3), S1. https://doi.org/10.1016/j.jval.2018.09.004
  43. Koleva-Kolarova, R. G., Daszczuk, A. M., de Jonge, C., Abu Hantash, M. K., Zhan, Z. Z., Postema, E. J., Feenstra, T. L., Pijnappel, R. M., Greuter, M. J. W., & de Bock, G. H. (2018). Corrigendum to: A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening (vol 109, pg 81, 2018). Maturitas, 114, 73. https://doi.org/10.1016/j.maturitas.2018.05.005
  44. Irawati, S., Wasir, R., Schmidt, A. F., Islam, A., Feenstra, T., Buskens, E., Wilffert, B., & Hak, E. (2018). Long-term incidence and risk factors of cardiovascular events in Asian populations: Systematic review and meta-analysis of population-based cohort studies. Pharmacoepidemiology and Drug Safety, 27(Suppl. 2), 83-83. https://doi.org/10.1080/03007995.2018.1491149
  45. Palmer, A. J., Si, L., Tew, M., Hua, X., Willis, M. S., Asseburg, C., McEwan, P., Leal, J., Gray, A., Foos, V., Lamotte, M., Feenstra, T., O'Connor, P. J., Brandle, M., Smolen, H. J., Gahn, J. C., Valentine, W. J., Pollock, R. F., Breeze, P., ... Clarke, P. M. (2018). Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge. Value in Health, 21(6), 724-731. https://doi.org/10.1016/j.jval.2018.02.002
  46. Rodriguez Sanchez, B., Alessie, R., Feenstra, T. L., & Angelini, V. (2018). The relationship between diabetes, diabetes-related complications and productive activities among older Europeans. European Journal of Health Economics, 19(5), 719-734. https://doi.org/10.1007/s10198-017-0911-9
  47. Koleva-Kolarova, R. G., Greuter, M. J. W., Feenstra, T. L., Vermeulen, K. M., de Vries, E. F. J., Parkin, D., Buskens, E., & de Bock, G. H. (2018). Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study. Oncotarget, 9(28), 19836-19846. https://doi.org/10.18632/oncotarget.24869
  48. Koleva-Kolarova, R. G., De Jonge, C., Abu Hantash, M. K., Zhan, Z., Postema, E. J., Feenstra, T. L., Pijnappel, R. M., Greuter, M. J., & De Bock, G. H. (2018). A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening. European Journal of Cancer, 92, S11-S12.
  49. Koleva-Kolarova, R. G., De Jonge, C., Abu Hantash, M. K., Zhan, Z., Postema, E. J., Feenstra, T. L., Pijnappel, R. M., Greuter, M. J., & De Bock, G. H. (2018). A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening. European Journal of Cancer, 92(Supp. 3), S11-S12. https://doi.org/10.1016/S0959-8049(18)30274-0
  50. Daszczuk, A. M., Greuter, M. J., Feenstra, T. L., Pijnappel, R. M., Vermeulen, K. M., Buls, N., & De Bock, G. H. (2018). Early health technology assessment of digital breast tomosynthesis in national breast cancer screening. European Journal of Cancer, 92, S89-S90.
  51. Koleva-Kolarova, R. G., Daszczuck, A. M., de Jonge, C., Abu Hantash, M. K., Zhan, Z. Z., Postema, E. J., Feenstra, T. L., Pijnappel, R. M., Greuter, M. J. W., & de Bock, G. H. (2018). A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening. Maturitas, 109, 81-88. https://doi.org/10.1016/j.maturitas.2017.12.009
  52. Suijkerbuijk, A. W. M., van Gils, P. F., Bonačić Marinović, A. A., Feenstra, T. L., Kortbeek, L. M., Mangen, M-J. J., Opsteegh, M., de Wit, G. A., & van der Giessen, J. W. B. (2018). The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Healthapproach. Zoonoses and Public Health, 65(1), 185-194. https://doi.org/10.1111/zph.12417
  53. van Asselt, T., Ramaekers, B., Corro Ramos, I., Joore, M., Al, M., Lesman-Leegte, I., Postma, M., Vemer, P., & Feenstra, T. (2018). Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research. Pharmacoeconomics, 36(1), 105-113. https://doi.org/10.1007/s40273-017-0572-7
Previous 1 2 3 4 Next

ID: 71774

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube